ArticleOncology reports2017

FIGNL1 is overexpressed in small cell lung cancer patients and enhances NCI-H446 cell resistance to cisplatin and etoposide.

Jian Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.